Catálogo de publicaciones - revistas
Science
Resumen/Descripción – provisto por la editorial
No disponible.
Palabras clave – provistas por la editorial
No disponibles.
Disponibilidad
| Institución detectada | Período | Navegá | Descargá | Solicitá |
|---|---|---|---|---|
| No detectada | desde mar. 1997 / hasta dic. 2023 | Science Journals |
Información
Tipo de recurso:
revistas
ISSN impreso
0036-8075
ISSN electrónico
1095-9203
Editor responsable
American Association for the Advancement of Science (AAAS)
País de edición
Estados Unidos
Fecha de publicación
1880-
Cobertura temática
Tabla de contenidos
A valley valve and electron beam splitter
Jing Li
; Rui-Xing Zhang
; Zhenxi Yin
; Jianxiao Zhang
; Kenji Watanabe
; Takashi Taniguchi; Chaoxing Liu
; Jun Zhu
<jats:title>Making a practical valleytronics device</jats:title> <jats:p> Two-dimensional materials with a hexagonal lattice, such as graphene, have two distinct “valleys” in their band structure. Researchers in the emerging field of valleytronics hope that these valley degrees of freedom can be exploited as information carriers, but making valleytronic devices is tricky. Li <jats:italic>et al.</jats:italic> created chiral valley Hall states on the boundary between oppositely gated regions of bilayer graphene. They then guided these so-called kink states through their sample using spatially modulated gating, demonstrating right and left turns, as well as a valley valve function. </jats:p> <jats:p> <jats:italic>Science</jats:italic> , this issue p. <jats:related-article xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" issue="6419" page="1149" related-article-type="in-this-issue" vol="362" xlink:href="10.1126/science.aao5989">1149</jats:related-article> </jats:p>
Palabras clave: Multidisciplinary.
Pp. 1149-1152
Photonic crystals for nano-light in moiré graphene superlattices
S. S. Sunku
; G. X. Ni; B. Y. Jiang
; H. Yoo; A. Sternbach
; A. S. McLeod; T. Stauber; L. Xiong; T. Taniguchi; K. Watanabe
; P. Kim
; M. M. Fogler
; D. N. Basov
<jats:title>Twisting a route for surface plasmons</jats:title> <jats:p> Graphene is an atomically thin material that supports highly confined plasmon polaritons, or nano-light, with very low loss. The properties of graphene can be made richer by introducing and then rotating a second layer so that there is a slight angle between the atomic registry. Sunku <jats:italic>et al.</jats:italic> show that the moiré patterns that result from such twisted bilayer graphene also provide confined conducting channels that can be used for the directed propagation of surface plasmons. Controlling the structure thereby provides a pathway to control and route surface plasmons for a nanophotonic platform. </jats:p> <jats:p> <jats:italic>Science</jats:italic> , this issue p. <jats:related-article xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" issue="6419" page="1153" related-article-type="in-this-issue" vol="362" xlink:href="10.1126/science.aau5144">1153</jats:related-article> </jats:p>
Palabras clave: Multidisciplinary.
Pp. 1153-1156
Salmonella persisters undermine host immune defenses during antibiotic treatment
Daphne A. C. Stapels
; Peter W. S. Hill; Alexander J. Westermann
; Robert A. Fisher
; Teresa L. Thurston
; Antoine-Emmanuel Saliba
; Isabelle Blommestein; Jörg Vogel
; Sophie Helaine
<jats:title> Actively persistent <jats:italic>Salmonella</jats:italic> </jats:title> <jats:p> A proportion of <jats:italic>Salmonella</jats:italic> cells can enter a reversible state of growth arrest, which allows them to tolerate environmental stress such as antibiotics. Stapels <jats:italic>et al.</jats:italic> found that these cells are not dormant but are actively modulating their environment. <jats:italic>Salmonella</jats:italic> within their host macrophage niche deployed a specialized type 3 secretory system called SPI-2 to deliver virulence factors, including SteE, into host cells. SteE changed the cytokine profile of the infected macrophages to reprogram them into a noninflammatory and infection-permissive state. Thus, when antibiotics were removed, the <jats:italic>Salmonella</jats:italic> could reemerge and cause disease. </jats:p> <jats:p> <jats:italic>Science</jats:italic> , this issue p. <jats:related-article xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" issue="6419" page="1156" related-article-type="in-this-issue" vol="362" xlink:href="10.1126/science.aat7148">1156</jats:related-article> </jats:p>
Palabras clave: Multidisciplinary.
Pp. 1156-1160
Quantifying the contribution of recessive coding variation to developmental disorders
Hilary C. Martin
; Wendy D. Jones
; Rebecca McIntyre
; Gabriela Sanchez-Andrade; Mark Sanderson; James D. Stephenson
; Carla P. Jones
; Juliet Handsaker
; Giuseppe Gallone
; Michaela Bruntraeger
; Jeremy F. McRae
; Elena Prigmore
; Patrick Short
; Mari Niemi
; Joanna Kaplanis; Elizabeth J. Radford
; Nadia Akawi
; Meena Balasubramanian
; John Dean
; Rachel Horton; Alice Hulbert; Diana S. Johnson; Katie Johnson
; Dhavendra Kumar; Sally Ann Lynch
; Sarju G. Mehta
; Jenny Morton; Michael J. Parker; Miranda Splitt
; Peter D. Turnpenny
; Pradeep C. Vasudevan; Michael Wright
; Andrew Bassett
; Sebastian S. Gerety
; Caroline F. Wright
; David R. FitzPatrick
; Helen V. Firth
; Matthew E. Hurles; Jeffrey C. Barrett
;
<jats:title>Genetic architecture of developmental disorders</jats:title> <jats:p> The genetics of developmental disorders (DDs) is complex. Martin <jats:italic>et al.</jats:italic> wanted to determine the degree of recessive inheritance of DDs in protein-coding genes. They examined the exomes of more than 6000 families in populations with high and low proportions of consanguineous marriages. They found that 3.6% of DDs in individuals of European ancestry involved recessive coding disorders, less than a tenth of the levels previously estimated. Furthermore, among South Asians with high parental relatedness, rather than most of the disorders arising from inherited variants, fewer than half had a recessive coding diagnosis. </jats:p> <jats:p> <jats:italic>Science</jats:italic> , this issue p. <jats:related-article xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" issue="6419" page="1161" related-article-type="in-this-issue" vol="362" xlink:href="10.1126/science.aar6731">1161</jats:related-article> </jats:p>
Palabras clave: Multidisciplinary.
Pp. 1161-1164
A mechanistic classification of clinical phenotypes in neuroblastoma
Sandra Ackermann
; Maria Cartolano; Barbara Hero
; Anne Welte; Yvonne Kahlert; Andrea Roderwieser; Christoph Bartenhagen; Esther Walter; Judith Gecht; Laura Kerschke
; Ruth Volland; Roopika Menon
; Johannes M. Heuckmann
; Moritz Gartlgruber; Sabine Hartlieb; Kai-Oliver Henrich; Konstantin Okonechnikov; Janine Altmüller; Peter Nürnberg
; Steve Lefever; Bram de Wilde
; Frederik Sand; Fakhera Ikram; Carolina Rosswog; Janina Fischer; Jessica Theissen; Falk Hertwig
; Aatur D. Singhi; Thorsten Simon; Wenzel Vogel; Sven Perner; Barbara Krug; Matthias Schmidt; Sven Rahmann
; Viktor Achter; Ulrich Lang; Christian Vokuhl; Monika Ortmann; Reinhard Büttner; Angelika Eggert
; Frank Speleman; Roderick J. O’Sullivan; Roman K. Thomas; Frank Berthold; Jo Vandesompele; Alexander Schramm
; Frank Westermann
; Johannes H. Schulte; Martin Peifer; Matthias Fischer
<jats:title>A systematic look at a childhood tumor</jats:title> <jats:p> Neuroblastomas—the most common tumor type in infants—develop from fetal nerve cells, and their clinical course is highly variable. Some neuroblastomas are fatal despite treatment, whereas others respond well to treatment and some undergo spontaneous regression without treatment. Ackermann <jats:italic>et al.</jats:italic> sequenced more than 400 pretreatment neuroblastomas and identified molecular features that characterize the three distinct clinical outcomes. Low-risk tumors lack telomere maintenance mechanisms, intermediate-risk tumors harbor telomere maintenance mechanisms, and high-risk tumors harbor telomere maintenance mechanisms in combination with RAS and/or p53 pathway mutations. </jats:p> <jats:p> <jats:italic>Science</jats:italic> , this issue p. <jats:related-article xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" issue="6419" page="1165" related-article-type="in-this-issue" vol="362" xlink:href="10.1126/science.aat6768">1165</jats:related-article> </jats:p>
Palabras clave: Multidisciplinary.
Pp. 1165-1170
LZTR1 is a regulator of RAS ubiquitination and signaling
Johannes W. Bigenzahn
; Giovanna M. Collu
; Felix Kartnig
; Melanie Pieraks; Gregory I. Vladimer
; Leonhard X. Heinz
; Vitaly Sedlyarov
; Fiorella Schischlik; Astrid Fauster
; Manuele Rebsamen
; Katja Parapatics; Vincent A. Blomen; André C. Müller
; Georg E. Winter
; Robert Kralovics; Thijn R. Brummelkamp
; Marek Mlodzik; Giulio Superti-Furga
<jats:title>Regulation of RAS by ubiquitination</jats:title> <jats:p> The protein LZTR1 is mutated in human cancers and developmental diseases. Work from two groups now converges to implicate the protein in regulating signaling by the small guanosine triphosphatase RAS. Steklov <jats:italic>et al.</jats:italic> showed that mice haploinsufficient for LZTR1 recapitulated aspects of the human disease Noonan syndrome. Their biochemical studies showed that LZTR1 associated with RAS. LZTR1 appears to function as an adaptor that promotes ubiquitination of RAS, thus inhibiting its signaling functions. Bigenzahn <jats:italic>et al.</jats:italic> found LZTR1 in a screen for proteins whose absence led to resistance to the tyrosine kinase inhibitors used to treat cancers caused by the BCR-ABL oncogene product. Their biochemical studies and genetic studies in fruitflies also showed that loss of LZTR1 led to increased activity of RAS and signaling through the mitogen-activated protein kinase pathway. </jats:p> <jats:p> <jats:italic>Science</jats:italic> , this issue p. <jats:related-article xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" issue="6419" page="1177" related-article-type="in-this-issue" vol="362" xlink:href="10.1126/science.aap7607">1177</jats:related-article> , p. <jats:related-article xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" issue="6419" page="1171" related-article-type="in-this-issue" vol="362" xlink:href="10.1126/science.aap8210">1171</jats:related-article> </jats:p>
Palabras clave: Multidisciplinary.
Pp. 1171-1177
Mutations in LZTR1 drive human disease by dysregulating RAS ubiquitination
M. Steklov
; S. Pandolfi
; M. F. Baietti
; A. Batiuk; P. Carai; P. Najm; M. Zhang; H. Jang
; F. Renzi; Y. Cai; L. Abbasi Asbagh; T. Pastor; M. De Troyer
; M. Simicek; E. Radaelli
; H. Brems
; E. Legius
; J. Tavernier; K. Gevaert
; F. Impens
; L. Messiaen; R. Nussinov
; S. Heymans; S. Eyckerman; A. A. Sablina
<jats:title>Regulation of RAS by ubiquitination</jats:title> <jats:p> The protein LZTR1 is mutated in human cancers and developmental diseases. Work from two groups now converges to implicate the protein in regulating signaling by the small guanosine triphosphatase RAS. Steklov <jats:italic>et al.</jats:italic> showed that mice haploinsufficient for LZTR1 recapitulated aspects of the human disease Noonan syndrome. Their biochemical studies showed that LZTR1 associated with RAS. LZTR1 appears to function as an adaptor that promotes ubiquitination of RAS, thus inhibiting its signaling functions. Bigenzahn <jats:italic>et al.</jats:italic> found LZTR1 in a screen for proteins whose absence led to resistance to the tyrosine kinase inhibitors used to treat cancers caused by the BCR-ABL oncogene product. Their biochemical studies and genetic studies in fruitflies also showed that loss of LZTR1 led to increased activity of RAS and signaling through the mitogen-activated protein kinase pathway. </jats:p> <jats:p> <jats:italic>Science</jats:italic> , this issue p. <jats:related-article xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" issue="6419" page="1177" related-article-type="in-this-issue" vol="362" xlink:href="10.1126/science.aap7607">1177</jats:related-article> , p. <jats:related-article xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" issue="6419" page="1171" related-article-type="in-this-issue" vol="362" xlink:href="10.1126/science.aap8210">1171</jats:related-article> </jats:p>
Palabras clave: Multidisciplinary.
Pp. 1177-1182
A DNA methylation reader complex that enhances gene transcription
C. Jake Harris
; Marion Scheibe
; Somsakul Pop Wongpalee
; Wanlu Liu; Evan M. Cornett
; Robert M. Vaughan
; Xueqin Li
; Wei Chen; Yan Xue
; Zhenhui Zhong
; Linda Yen; William D. Barshop; Shima Rayatpisheh; Javier Gallego-Bartolome; Martin Groth; Zonghua Wang; James A. Wohlschlegel
; Jiamu Du
; Scott B. Rothbart
; Falk Butter
; Steven E. Jacobsen
<jats:title>DNA methylation promotes transcription</jats:title> <jats:p> DNA methylation generally represses transcription, but in some instances, it has also been implicated in transcription activation. Harris <jats:italic>et al.</jats:italic> identified a protein complex in <jats:italic>Arabidopsis</jats:italic> that is recruited to chromatin by DNA methylation. This complex specifically activated the transcription of genes that are already mildly transcribed but had no effect on transcriptionally silent genes such as transposable elements. The complex thereby counteracts the repression effect caused by transposon insertion in neighboring genes while leaving transposons silent. Thus, by balancing both repressive and activating transcriptional effects, DNA methylation can act to fine-tune gene expression. </jats:p> <jats:p> <jats:italic>Science</jats:italic> , this issue p. <jats:related-article xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" issue="6419" page="1182" related-article-type="in-this-issue" vol="362" xlink:href="10.1126/science.aar7854">1182</jats:related-article> </jats:p>
Palabras clave: Multidisciplinary.
Pp. 1182-1186
Viscous control of cellular respiration by membrane lipid composition
Itay Budin
; Tristan de Rond
; Yan Chen
; Leanne Jade G. Chan; Christopher J. Petzold
; Jay D. Keasling
<jats:title>How membrane viscosity affects respiration</jats:title> <jats:p> In bacteria, energy production by the electron transport chain occurs at cell membranes and can be influenced by the lipid composition of the membrane. Budin <jats:italic>et al.</jats:italic> used genetic engineering to influence the concentration of unsaturated branched-chain fatty acids and thus control membrane viscosity (see the Perspective by Schon). Experimental measurements and mathematical modeling indicated that rates of respiratory metabolism and rates of cell growth were dependent on membrane viscosity and its effects on diffusion. Experiments on yeast mitochondria also showed similar effects. Maintaining efficient respiration may thus place evolutionary constraints on cellular lipid composition. </jats:p> <jats:p> <jats:italic>Science</jats:italic> , this issue p. <jats:related-article xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" issue="6419" page="1186" related-article-type="in-this-issue" vol="362" xlink:href="10.1126/science.aat7925">1186</jats:related-article> ; see also p. <jats:related-article xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" issue="6419" page="1114" related-article-type="in-this-issue" vol="362" xlink:href="10.1126/science.aav7629">1114</jats:related-article> </jats:p>
Palabras clave: Multidisciplinary.
Pp. 1186-1189
New Products
<jats:p>A weekly roundup of information on newly offered instrumentation, apparatus, and laboratory materials of potential interest to researchers.</jats:p>
Palabras clave: Multidisciplinary.
Pp. 1193-1193